Cellbyte is an AI-driven copilot designed for Pricing & Market Access (P&MA) teams in the pharmaceutical industry. It enables users to perform complex data analyses on clinical, regulatory, HTA and pricing-related data and to extract qualitative insights from industry documents using natural language queries. Critical answers are provided in seconds, thereby transforming the development of drug launch strategies by radically reducing the time and effort required for research. Additionally, advanced analytics enables the discovery of untapped insights across gigabytes of pharmaceutical data. Especially for orphan drugs, Cellbyte offers enhanced data accessibility, enabling deep dives into the rare disease landscape. The founders Daniel, Felix, and Samuel are serial entrepreneurs with a combined experience of 5+ years in the pharmaceutical industry.